Detalles de la búsqueda
1.
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Neuropsychopharmacology
; 42(9): 1925-1926, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28701746
2.
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Neuropsychopharmacology
; 42(5): 1049-1057, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28042871
3.
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
J Psychopharmacol
; 29(9): 943-60, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26246443
4.
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
Neuropsychopharmacology
; 42(7): 1559, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28496172
Resultados
1 -
4
de 4
1
Próxima >
>>